Evogene (EVGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.70M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 3.6% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 53.1, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about EVGN
News
EVGN Valuation
EVGN Profitability: Margins, ROIC and FCF
Evogene (EVGN) has a gross margin of -123.9%, an operating margin of -858.0% and a net margin of 0.0%. It posts a -884.8% FCF margin.
- Gross margin
- -123.9%
- Operating margin
- -858.0%
- Net margin
- 0.0%
- ROE
- -182.7%
- FCF margin
- -884.8%
- FCF yield
- -242.0%
Evogene Competitors
The companies most similar to Evogene (EVGN) include Soligenix, GT Biopharma and In8bio.
Sector: Healthcare
Companies most similar to EvogeneEVGN Bull Case vs Bear Case
Bear case
- EVGN's quarterly revenue changed -60.7% year over year.
EVGN Earnings: Beat Rate and Next Report
Evogene (EVGN) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is confirmed on Nov 19, 2026.
- Beat rate
- 4 of 8 quarters (50.0%)
- Average surprise
- -1.7%
- EPS estimate (fiscal period ending Sep 30, 2026)
- -$0.19
- Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
- 1 up, 0 down
EVGN Earnings Date
EVGN reports Nov 19, 2026, before the open. The date is confirmed.
EVGN Earnings Call
The latest EVGN earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptUpdated Aug 23, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About EVGN
When does EVGN report earnings?
Evogene (EVGN) is confirmed to report earnings on Nov 19, 2026.
Does EVGN pay dividends?
Evogene (EVGN) does not currently pay a regular dividend.
What is EVGN's market cap?
Evogene (EVGN) has a market capitalization of $6.70M with a current stock price of $0.39.
EVGN pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.